Evidence map›Paper›PMID 24386392›Full record

ArticlePloS one2013

Rapid identification of sequences for orphan enzymes to power accurate protein annotation.

Kevin R Ramkissoon, Jennifer K Miller, Sunil Ojha, Douglas S Watson, Martha G Bomar, Amit K Galande, Alexander G Shearer

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Profiling the orphan enzymes.Biology direct · 2014
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin R RamkissoonBiosciences Division, SRI International, Harrisonburg, Virginia, United States of America.
Jennifer K MillerBiosciences Division, SRI International, Harrisonburg, Virginia, United States of America.
Sunil OjhaBiosciences Division, SRI International, Harrisonburg, Virginia, United States of America.
Douglas S WatsonBiosciences Division, SRI International, Harrisonburg, Virginia, United States of America.
Martha G BomarBiosciences Division, SRI International, Harrisonburg, Virginia, United States of America.
Amit K GalandeBiosciences Division, SRI International, Harrisonburg, Virginia, United States of America.
Alexander G ShearerClover Collective, Mountain View, California, United States of America.

Funding

Resolving the Problem of Orphan Enzyme ActivitiesR01GM086755 · NIGMS · SRI INTERNATIONAL · PI DUBOIS, JENNIFER L · 2009 to 2010
$630k
NIGMS NIH HHS GM086755NIGMS NIH HHS R01 GM086755
6 · The paper itself

Abstract

The power of genome sequencing depends on the ability to understand what those genes and their proteins products actually do. The automated methods used to assign functions to putative proteins in newly sequenced organisms are limited by the size of our library of proteins with both known function and sequence. Unfortunately this library grows slowly, lagging well behind the rapid increase in novel protein sequences produced by modern genome sequencing methods. One potential source for rapidly expanding this functional library is the "back catalog" of enzymology--"orphan enzymes," those enzymes that have been characterized and yet lack any associated sequence. There are hundreds of orphan enzymes in the Enzyme Commission (EC) database alone. In this study, we demonstrate how this orphan enzyme "back catalog" is a fertile source for rapidly advancing the state of protein annotation. Starting from three orphan enzyme samples, we applied mass-spectrometry based analysis and computational methods (including sequence similarity networks, sequence and structural alignments, and operon context analysis) to rapidly identify the specific sequence for each orphan while avoiding the most time- and labor-intensive aspects of typical sequence identifications. We then used these three new sequences to more accurately predict the catalytic function of 385 previously uncharacterized or misannotated proteins. We expect that this kind of rapid sequence identification could be efficiently applied on a larger scale to make enzymology's "back catalog" another powerful tool to drive accurate genome annotation.

Indexed as

Databases, ProteinCatalysisEnzymesMass SpectrometryMolecular Sequence AnnotationSequence Analysis, ProteinEnzymes

Identifiers

PMID24386392
PMCPMC3875567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.